Ekso Bionics Holdings Inc expected to post a loss of 24  cents a share - Earnings Preview

Chronoscale

27/04/2021 22:30

* Ekso Bionics Holdings Inc  EKSO.OQ   EKSO.O  is expected to
show a rise in quarterly revenue when it reports results on
April 29.
* The Richmond California, California-based company is expected
to report  a 104.4% increase in revenue to $3 million from $1.47
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for Ekso Bionics Holdings
Inc is for a loss of 24 cents per share. For the same quarter
last year, the company reported a loss of 44 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months.​
* Wall Street's median 12-month price target for Ekso Bionics
Holdings Inc is $10​, about 43.5% above​ its last closing price
of $5.65. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.30       -0.30      -0.48     Missed  -60
 Sep. 30 2020  -0.39       -0.39      0.30      Beat    176.9
 Jun. 30 2020  -0.55       -0.55      -1.88     Missed  -238.7
                                                        ​
 Mar. 31 2020  -0.61       -0.61      -0.44     Beat    27.9
 Dec.          -0.66​      -0.65      -0.60     Beat    7.7​
 31​ 2019​                                              
 Sep. 30 2019  -0.90       -1.05      0.00      Beat    100​
 Jun. 30 2019              -1.20      -0.60     Beat    50
 Mar. 31 2019              -1.20      -1.20     Met     0
 This summary was machine generated April 27 at 21:30 GMT.  All
figures in US dollars unless otherwise stated